Unrestricted funding for the in-person Scottsdale RAND Appropriateness Panel meeting was generously provided by Warner-Chilcott, Abbott, and Shire. Unrestricted funding for the BRIDGe group is provided by Abbott, Salix, Shire, UCB, and Warner-Chilcott
Original Article
You have free access to this content
Setting priorities for comparative effectiveness research in inflammatory bowel disease: Results of an international provider survey, expert rand panel, and patient focus groups†
Article first published online: 15 FEB 2012
DOI: 10.1002/ibd.22920
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.
Additional Information
How to Cite
Cheifetz, A.S., Melmed, G.Y., Spiegel, B., Talley, J., Devlin, S.M., Raffals, L., Irving, P.M., Jones, J., Kaplan, G.G., Kozuch, P., Sparrow, M., Velayos, F., Baidoo, L., Bressler, B. and Siegel, C.A. (2012), Setting priorities for comparative effectiveness research in inflammatory bowel disease: Results of an international provider survey, expert rand panel, and patient focus groups. Inflamm Bowel Dis, 18: 2294–2300. doi: 10.1002/ibd.22920
- †
Publication History
- Issue published online: 15 NOV 2012
- Article first published online: 15 FEB 2012
- Manuscript Accepted: 24 JAN 2012
- Manuscript Received: 23 DEC 2011

1536-4844/asset/IBD_left.gif?v=1&s=9aca2b5041534c51cac4bb66560294c77a457a07)
1536-4844/asset/IBD_right.gif?v=1&s=402e3e241083497ae622916e85e47f64138255a4)
